Kazutaka Yoshinaga
HealthTech Deep Dive
Welcome to Health Tech Deep Dive, the podcast that delves into the forefront of healthcare technology and innovation, exploring transformative advancements from around the globe. Each episode uncovers how groundbreaking ideas and cutting-edge technologies are pushing the boundaries of what’s possible in the field of health tech, with a special focus on the interplay between global trends and localized innovation. The voices of this podcast are generated by AI.
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Approval granted for insurance coverage of 3 medical devices, including an app to assist with alcohol reduction (CureApp). Is the reimbursement price of $50 for the alcohol reduction app reasonable? 22.07.2025 12:29
This podcast episode primarily discusses recent advancements and approvals in the Japanese healthcare technology sector, focusing on innovative medical devices and the increasing integration of artificial intelligence in clinical settings . Key highlights include the Central Social Insurance Medical Council's (Chuikyo) approval of three new medical devices for insurance coverage, such as...
Samsung acquires Xealth, a digital health platform that provides electronic medical record APIs. The battle for wearable devices and the battle for data acquisition are both heating up. 14.07.2025 13:44
This podcast discusses significant advancements in digital health and biotechnology , highlighting Samsung's acquisition of Xealth to integrate wearable health data with electronic health records, thereby intensifying the competition among tech giants like Apple and Google in clinical workflow integration. The text also details JMDC's new AI-powered "Pep Up Sleep" service ai...
OPERE, operator of medical communication SaaS “Pokesapo,” raises 400 million yen in pre-Series A funding. How does it differ from patient explanation support services such as Contrea and MediOS? 07.07.2025 16:10
This collection of articles explores recent innovations and challenges within the healthcare technology sector. OPERe's "Pokesapo" service is highlighted for its successful funding round and unique approach to patient-provider communication, leveraging existing hospital materials and the LINE platform to streamline information sharing. The text also discusses HELTEC's new fall ri...
The most toxic substances for the liver are sweetened beverages such as 100% fruit juice, vegetable juice, and energy drinks. Solid foods are OK, but liquids are not? 30.06.2025 17:03
This compilation of news and insights covers various health and technology topics, primarily focusing on medical advancements and wellness information . The sources discuss dietary impacts on liver health , specifically highlighting the dangers of sugary liquid-based drinks and explaining how fructose in liquid form can damage the liver . It also explores the increasing incidence of fatty li...
Fujifilm uses AI to generate diagnostic findings, reducing the burden by 30 million cases per year. Is it true that humans are necessary to take responsibility? 23.06.2025 12:58
This podcastFujifilm uses AI to generate diagnostic findings, reducing the burden by 30 million cases per year. Is it true that humans are necessary to take responsibility? explores the increasing integration of artificial intelligence (AI) in healthcare , highlighting several key developments. Fujifilm plans to implement AI for generating medical image reports by 2028 , aiming to significantly...
Kakehashi completes Series D round of financing worth approximately 140 million dollars. Musubi has been installed in 14,000 locations, likely surpassing EM Systems to become the industry leader 16.06.2025 13:03
This compilation of news and insights from Kazutaka Yoshinaga offers a comprehensive look into the evolving landscape of medical healthcare in Japan and beyond. It highlights Kakehashi's significant Series D funding and their Musubi system's rapid market dominance in electronic prescription records, showcasing their expansion into patient monitoring via LINE and integrating healthcare serv...
Kirin's AI prediction application “Premedi” wins second Japan New Business Award. Two approaches: AI demand prediction for long-tail pharmaceuticals and loss minimization through delivery and buyback. 09.06.2025 18:44
This episode presents an overview of recent developments in the Japanese healthcare and technology sectors. It highlights Kirin's award-winning "Premedi" service, which uses AI to predict demand for less common pharmaceuticals and employs a delivery and buyback model to minimize pharmacy losses. The article also mentions Panasonic's entry into femtech, a company called Medii addi...
OpenAI announces “HealthBench” to evaluate medical AI models. LLM > specialist doctors, but there is almost no difference in scores between “LLM alone” and “doctor + LLM”... 02.06.2025 17:20
This week in medical news, OpenAI announced HealthBench , a new way to evaluate medical AI models that suggests large language models (LLMs) may soon surpass specialists, though LLM-supported doctors currently perform similarly to standalone LLMs. In another development, AI Scientist, a multi-agent system, discovered a promising drug candidate for a major cause of blindness, demonstrating a clo...
How far can digital therapeutics go? Differences between Japan and the US in DTx regulations, insurance reimbursement, and penetration rates. 29.05.2025 14:29
This podcast provides an overview of the current state of Digital Therapeutics (DTx), focusing on the differences in adoption and regulatory landscapes between the United States and Japan. It explores the challenges and opportunities for DTx, discussing factors like drug pricing, insurance reimbursement, regulatory approval processes, and the perspectives of both doctors and patients. The podcast...
Medley 2025 Q1 Results. New Job Medley Spot Launched and Generation AI Utilization is One of the Pillars of Strategy in Medical PF 14.05.2025 12:30
This PodCast discusses Medley's Q1 2025 financial results. In particular, it describes the 37% YoY increase in revenues, driven primarily by growth in the Human Resources Platform segment. The report also details the newly launched “job medley spot” and the strategic use of generative AI in the healthcare platform. The author also expresses his personal opinion that the introduction of medical...
M3 2024 Financials Review: M3 Digical is doing well with 400 installations in the quarter, but what is the impact of the standardized EHR promoted by the government? 06.05.2025 7:00
This podcast discusses the full year 2024 financial results and outlook for M3, a technology company in the healthcare sector. It is noted that while sales have remained strong, operating profit margins have declined. In particular, the mainstay medical platform and clinical trial businesses experienced declines in both sales and profits due to the end of special demand. On the other hand, the sta...
Apple's AI Doctor: Shaping the Future of Wearable Health 02.04.2025 16:08
Apple is reportedly planning to significantly improve its healthcare app and introduce an AI Doctor feature in the spring of 2026. This will allow AI to analyze biometric data collected from wearable devices such as the Apple Watch and provide personalized health advice to users. Following this trend, other wearable companies such as Whoop and Oura have also implemented AI agent functions, and it...
M3 acquired benefits provider eWell as a subsidiary for $68M, feeling steered toward B2B2C model? 30.03.2025 20:53
M3 plans to acquire 51.0% of Ewell's shares from Tokyu Land Corporation for ¥10.2 billion, making it a subsidiary of M3 as of April 1, 2025. On November 14, 2023, M3 announced plans to conduct a TOB (takeover bid) for Benefit One, which is owned by Pasona Group, to make it a subsidiary. However, Dai-ichi Life Insurance conducted a TOB, a takeover bid without consent, at ¥2,173 per share, which...
The Future of the Genetic Testing Market: 23andMe's Share Price Plunge Highlights Challenges and Value-Added Offerings Other Than B2B2C Models and SNPs 27.03.2025 16:07
This podcast examines the current status and challenges of the genetic testing market, especially the limitations of its business model and new strategies for the future against the backdrop of 23andMe's plummeting stock price. While introducing the trends of major domestic and overseas players, the article proposes solutions to the challenges of monetization, such as the introduction of a sub...
Analysis of components, costs, and development difficulty required for smart ring development 24.03.2025 11:35
In this podcast, the University of Tokyo startup issin explains how it launched its sleep-focused Smart Recovery Ring and provides an overview of the product. While comparing the ring to its predecessor, the Oura ring, the PodCast also touches on the sensors and component configurations required for the smart ring, as well as an estimate of development costs, suggesting that the technological hurd...
Why was Oura able to cross the chasm? What will be the future competitive advantage due to competitors' entry into the buy-out model? 22.03.2025 13:13
This podcast discusses how Oura Ring, a pioneer in the smart ring market, can maintain its competitive advantage even after competitors enter the market. factors that helped Oura overcome its initial challenges and gain user acceptance include its focus on improving sleep quality, product improvements, sleek design, and celebrity marketing strategies. On the other hand, latecomers are entering the...
Pick four noteworthy novelty healthcare products announced at CES 2025 13.01.2025 16:24
Learn about four innovative healthcare products presented at CES 2025. Cure Silk, a chronic wound care solution, combines an AI app with a silk elastin patch. The battery-free Smart Diaper generates electricity from urine as an electrolyte and notifies the user when he or she urinates; Eli Health's Hormometer, a home hormone testing device, offers a simple saliva-based test; and the Hormometer, a...
Hims & Hers Q3 2024 Financial and Operational Review 12.01.2025 18:15
This document is a discussion of the third quarter 2024 financial report of online healthcare services provider Hims & Hers, Inc. The company's success factors include personalized medicine using electronic medical records and AI/machine learning and a competitive pricing strategy. In personalized medicine, the report highlights the company's ability to achieve high treatment retention rates b...
LLM-Powered Medical Summaries: A Market Forecast 04.01.2025 19:17
This podcast discusses the current status and future projections regarding the use of large-scale language models (LLMs) to support the creation of referral letters and discharge summaries in the medical field. Examples from Japan and overseas, including OpTim, Infocom, and a demonstration experiment between Mie University and NTT, are introduced, and the importance of linking with electronic medi...
Intuitive Surgical's Da Vinci: Market Dominance and Future Competition 09.12.2024 21:09
A report on Intuitive Surgical's Da Vinci surgical robot Q3 2024 financial results and a competitive analysis of the market, showing Da Vinci's high market share (approximately 80%) and high profitability (Recurring Revenue 83%), as well as an analysis of Intuitive Surgical's competitors, including Stryker, Johnson & Johnson, and Medtronic. The report also analyzes the trends of competitors su...
Hippocratic AI's Medical LLM Patent 02.12.2024 12:25
Hippocratic AI, a company advancing the development of healthcare-focused large language models (LLMs) under the name "Polaris," has announced that it has been granted a patent by the United States Patent and Trademark Office. Polaris' "Constellation Architecture" leverages a system where multiple specialized models work collaboratively, rather than relying on a single model. This innovative desig...
Doximity’s Winning Formula: Pharma Partnerships and AI Tools Shine in Q2 2024 30.11.2024 18:13
Doximity ($DOCS), a leading platform for U.S. physicians, reported strong results for the second quarter of fiscal year 2024, with both revenue and EBITDA significantly surpassing the previous year’s figures. This success was driven by its targeted approach through advertising agencies to pharmaceutical companies and the expansion of services to nurse practitioners (NPs). Revenue from the top 20 p...
Why do point incentives work for physicians who would not fit in the hourly wage scale? 27.11.2024 12:18
This text analyzes the evolution of point incentive measures in Japanese physician platforms and their effectiveness. Initially, points were awarded for clicking to view videos, but the measures became more complex to ensure viewing time, and despite being irrational in terms of physicians' time efficiency, the study points out that they continue due to psychological factors such as collection hab...
Why are specialized electronic medical records (EMRs) for private healthcare emerging from startups and thriving? 11.11.2024 3:33
The DX tool "B4A," specialized for private healthcare clinics, has integrated with "Gangnam Unni" through the "Easy Reservation Manager for Aesthetic Clinics." The initiative aims to increase lead customers for clinics by making the patient reservation experience more seamless.
JMDC FY25Q2 financial review. Health Big Data business expands; 2×2 synergies? 10.11.2024 7:49
On November 5, 2024, JMDC, Inc., the macro-composition medical data company in Japan, released its financial results for the second quarter of FY25. Here’s a detailed analysis of the key takeaways and implications
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.